Otrivin Menthol (Xylometazoline Hydrochloride)

Xylometazoline Hydrochloride, the active ingredient in Otrivin Menthol, is an Alpha‑2‑adrenergic agonist presented as a nasal spray for topical intranasal use. It relieves nasal congestion associated with common colds, sinusitis and allergic rhinitis in adults and children.

GNH USA supplies Otrivin Menthol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Otrivin Menthol (xylometazoline) acts on nasal mucosal blood vessels to reduce congestion. It is indicated for: - Common cold: alleviates nasal blockage and improves airflow. - Acute sinusitis: reduces swelling of the nasal passages, facilitating drainage. - Allergic rhinitis: decreases nasal congestion caused by seasonal or perennial allergens. - Upper respiratory tract infections: eases nasal obstruction associated with viral infections.

Adverse reactions to Otrivin Menthol are generally mild and reversible.

Common Side Effects: - Burning or stinging sensation in the nose. - Nasal dryness or irritation. - Sneezing shortly after application. - Mild headache. - Transient taste disturbance.

Serious or Rare Side Effects: - Persistent nasal irritation or ulceration. - Severe headache or facial pain. - Hypertension or increased heart rate. - Allergic reactions such as rash, itching or swelling. - Nasal septum perforation with prolonged use.

Before using Otrivin Menthol, consider the following safety measures: - Age restriction: not recommended for children under 6 years without medical advice. - Duration of use: limit to 3‑5 days to avoid rebound congestion. - Pre‑existing conditions: use cautiously in patients with hypertension, heart disease, diabetes, thyroid disorders, or glaucoma. - Pregnancy and lactation: consult a healthcare professional before use. - Concomitant nasal medications: avoid using other topical decongestants simultaneously. - Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Xylometazoline may interact with other medicines or substances. Monitor the following:

Major Interactions (Avoid): - Mono‑Mono‑mono  :  

Moderate  : -   t